46 related articles for article (PubMed ID: 28468038)
1. The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL.
Possati-Resende JC; Fregnani JH; Kerr LM; Mauad EC; Longatto-Filho A; Scapulatempo-Neto C
PLoS One; 2015; 10(7):e0134445. PubMed ID: 26230097
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis.
Chen CC; Huang LW; Bai CH; Lee CC
Ann Saudi Med; 2016; 36(4):245-51. PubMed ID: 27478909
[TBL] [Abstract][Full Text] [Related]
3. Validation of an on-chip p16
Hashimoto K; Kumagai T; Nomura K; Miyagawa Y; Tago S; Takasaki K; Takahashi Y; Nishida H; Ichinose T; Hirano M; Hiraike H; Wada-Hiraike O; Sasajima Y; Kim SH; Nagasaka K
Sci Rep; 2023 Oct; 13(1):17052. PubMed ID: 37816765
[TBL] [Abstract][Full Text] [Related]
4. Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2-3 in Thai women infected with high-risk types of human papillomavirus.
Srisuttayasathien M; Kantathavorn N; Luasiripanthu T; Petchjorm S; Samrarn J; Ittiamornlert P; Krisorakun W; Vanichtantikul A; Wetcho T; Saeloo S
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):192-198. PubMed ID: 38485314
[TBL] [Abstract][Full Text] [Related]
5. Association between p16/Ki-67 dual stain cytology results prior to and 6 months after LLETZ treatment for CIN and the follow-up regimen three years after treatment: a retrospective cohort study.
Packet B; Goyens J; Weynand B; Poppe W; Dewilde K
Arch Gynecol Obstet; 2024 Jul; 310(1):493-499. PubMed ID: 38806944
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dual p16/Ki-67 immunostaining on anal cytology specimens.
Smithgall MC; Towne WS; Gonzalez AA; Cimic A
Diagn Cytopathol; 2024 Apr; ():. PubMed ID: 38666389
[TBL] [Abstract][Full Text] [Related]
7. Performance of P16
Hou J; Du H; Wang C; Song F; Qu X; Wu R
Front Oncol; 2024; 14():1332172. PubMed ID: 38863645
[TBL] [Abstract][Full Text] [Related]
8. The importance of combined HPV and CINtec® PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma.
Voidăzan TS; Budianu MA; Cotoi OS; Turdean SG
Rom J Morphol Embryol; 2024; 65(1):99-105. PubMed ID: 38527989
[TBL] [Abstract][Full Text] [Related]
9. A cocktail of p16
Wang HR; Li YC; Guo HQ; Yu LL; Wu Z; Yin J; Liao GD; Qu YM; Jiang Y; Wang D; Chen W
Oncotarget; 2017 Oct; 8(48):83890-83899. PubMed ID: 29137390
[TBL] [Abstract][Full Text] [Related]
10. Is it practical to add the p16/Ki67 immunohistochemical dual staining into liquid-based cytology for cervical cancer screening?
Li YT; Lee NR; Chang WH
Taiwan J Obstet Gynecol; 2024 May; 63(3):437-438. PubMed ID: 38802218
[No Abstract] [Full Text] [Related]
11. Comparison of HPV 16/18 Genotyping and p16/Ki67 Dual Staining for Detection of High-Grade Cervical Lesion in Patients with Low-Grade Cervical Smears.
Chadha S; Gandhi G; Hedau ST; Gupta R
J Obstet Gynaecol India; 2023 Jun; 73(3):248-253. PubMed ID: 37324372
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of P16 Immunohistochemistry Positive Staining and Its Correlation to Clinical and Radiological Staging of Squamous Cell Carcinoma of the Cervix.
El Sokkary HH; Sheta E
J Obstet Gynaecol India; 2023 Oct; 73(Suppl 1):142-149. PubMed ID: 37916018
[TBL] [Abstract][Full Text] [Related]
13. Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer.
Bose M; Sunder Singh S; Ganesharaja S; Chiwate AS; Hingmire SJ; Rajkumar T
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2337-2346. PubMed ID: 37505764
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A/p16 evaluation in cytology specimens.
Xing J; Griffith CC
Cancer Cytopathol; 2023 Nov; 131(11):672-676. PubMed ID: 37068112
[No Abstract] [Full Text] [Related]
15. Letter to "Correlation of immediate prevalence of cervical squamous cell precancers and cancers with HPV genotype and age in women with LSIL cytology".
Chen L; Niu S; Zhou F
Diagn Cytopathol; 2024 Jul; 52(7):401. PubMed ID: 38532659
[No Abstract] [Full Text] [Related]
16. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases].
Yu J; Zhu HT; Zhao JJ; Su JZ; Xia YD
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):323-326. PubMed ID: 28468038
[No Abstract] [Full Text] [Related]
17. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
18. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
[TBL] [Abstract][Full Text] [Related]
19. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D
Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
